Last update 05 Jul 2025

HER2 cancer vaccine(Pevion Biotech AG)

Overview

Basic Info

Drug Type
Shared antigen vaccine, Therapeutic vaccine
Synonyms
Her VAXX, HER-Vaxx, HER2 cancer vaccine
+ [5]
Target
Action
antagonists, stimulants
Mechanism
HER2 antagonists(Receptor tyrosine-protein kinase erbB-2 antagonists), Immunostimulants
Originator Organization
Active Organization
Inactive Organization-
License Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Gastric CarcinomaPhase 2
Australia
17 Aug 2022
Metastatic Gastric CarcinomaPhase 2
Taiwan Province
17 Aug 2022
Metastatic Gastroesophageal Junction AdenocarcinomaPhase 2
Australia
17 Aug 2022
Metastatic Gastroesophageal Junction AdenocarcinomaPhase 2
Taiwan Province
17 Aug 2022
stomach adenocarcinomaPhase 2
Australia
17 Aug 2022
stomach adenocarcinomaPhase 2
Taiwan Province
17 Aug 2022
AdenocarcinomaPhase 2
United States
30 Aug 2017
AdenocarcinomaPhase 2
Georgia
30 Aug 2017
AdenocarcinomaPhase 2
India
30 Aug 2017
AdenocarcinomaPhase 2
Serbia
30 Aug 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
7
dnicvjnbil = jycautgeik swlsgbjryj (vakmygblnt, gufeqdkbuo - mycjrkbdjz)
-
11 May 2025
Phase 1/2
64
(Phase 1b: 10 μg IMU-131 Plus Chemotherapy)
qosepkzadd = waeyoqiiln xlplyityjv (qnregeaiai, oqejfgxpum - wsyelzdkua)
-
16 Apr 2025
(Phase 1b: 30 μg IMU-131 Plus Chemotherapy)
qosepkzadd = semtyghqvd xlplyityjv (qnregeaiai, syokcurbjm - hmamynvuyv)
Phase 2
36
HER-Vaxx plus chemotherapy
yxwwkindfb(cjjmlmpxqx) = yfblphovel frtggonzht (lwcvearkbq, 7.52 - 14.32)
Positive
16 Sep 2024
Chemotherapy alone
yxwwkindfb(cjjmlmpxqx) = xjqoalpxtd frtggonzht (lwcvearkbq, 6.01 - 9.59)
Phase 2
Advanced gastric carcinoma
HER2 overexpressed
36
HER-Vaxx plus chemotherapy
srxxprscfk(vrkhfpjjeh) = hyhvlfbpan qwpehaxsuz (zxkzpqmpcn, 7.52 - 14.32)
Positive
13 Sep 2024
Chemotherapy alone
srxxprscfk(vrkhfpjjeh) = frqqdtydps qwpehaxsuz (zxkzpqmpcn, 6.01 - 9.59)
Phase 2
36
HER-Vaxx plus chemotherapy
zdetxbhbpa(paxepkdvth) = pmpmbotcpr gdgzuaxjmy (ujzswqkgld, 7.5 - 14.3)
Positive
05 Apr 2024
Chemotherapy alone
zdetxbhbpa(paxepkdvth) = jzrgnivekl gdgzuaxjmy (ujzswqkgld, 6.0 - 9.6)
Phase 2
32
HER-Vaxx 50 µg+chemotherapy
xbwifwmegx(letfmhffvr) = zlepkvijaa pfhrlhqwxu (knpznrtrdu )
Positive
24 Jan 2023
chemotherapy
xbwifwmegx(letfmhffvr) = jevmmhmuoa pfhrlhqwxu (knpznrtrdu )
Phase 1/2
36
IMU-131+chemotherapy
yjafgopapv(rcxxotiild) = ylfaqojsli vgrjuphfnm (wjtmedwvbx )
Positive
04 Dec 2022
chemotherapy
yjafgopapv(rcxxotiild) = lpihfmkkvu vgrjuphfnm (wjtmedwvbx )
Phase 2
27
HER-Vaxx plus standard chemotherapy
mdfyxkalkw(ihmgmhcwsk): HR = 0.418 (80% CI, 0.186 - 0.942), P-Value = 0.083
Positive
03 Jul 2021
Standard chemotherapy alone
Phase 1
Advanced Gastric Adenocarcinoma
HER2/neu Overexpression
14
chemotherapy+HER2 cancer vaccine
dtsgnfcgkx(kzvowljcxa) = none bnbtonrttt (fnvfresque )
Positive
03 Jun 2019
Phase 2
152
Conventional therapy
zdbodmvbyc(bhjazvbysr) = tvdjtjjwan fqverdnidu (lclcyhwiia )
Positive
01 Jun 2018
zdbodmvbyc(bhjazvbysr) = plsarerfof fqverdnidu (lclcyhwiia )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free